Skip to main content
Premium Trial:

Request an Annual Quote

Orchid BioSciences, First Genetic Trust Ink Pharmacogenetic-Service Alliance

NEW YORK, March 5 - Orchid BioSciences and First Genetic Trust on Tuesday said they plan to co-develop and market a range of pharmacogenetic services to the private sector, academia, and health-care providers.

The alliance hopes to provide researchers the tools to asses the correlates between genotypes and phenotypes. Specifically, it seeks to generate patient registries and support clinical trials, develop and validate assays, and provide genotyping services, bioinformatics, and data management.

FGT will bring it the partnership its genomic data-banking services, trial management, and patient registries to the alliance, while Orchid will offer its high throughput genotyping services and associated data support.

Financial terms of the agreement were not disclosed.

"As pharmacogenetics moves from the lab into clinical studies and the physician's office, we expect that our combined capabilities will help make possible the routine use of genomic data by medical researchers, manufacturers of therapeutics and diagnostics and health care providers," Jack T. Ball Jr., senior vice president and general manager of Orchid's Life Sciences unit, said in a statement.

Added Arthur Holden, chairman and CEO of FGT, the collaboration "should enable more rapid and efficient discovery, development and delivery of molecular assays and pharmacogenetic drugs."

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.